Change in PDL Status for Otic Antibiotics Drug Class Effective Dec. 18, 2023

Effective Dec. 18, 2023, HHSC removed the non-preferred status for generic ciprofloxacin/dexamethasone otic drops on the Preferred Drug List (PDL). This change was made because the manufacturer discontinued the brand-name Ciprodex otic drops. The preferred status of brand-name Ciprodex will not change. This will allow the existing stock of these medications to be used. HHSC removed the non-preferred status for the following drugs, effective Dec. 18, 2023:

These changes will allow prescribers to prescribe the generic otic drops without requiring PDL prior authorization and continue to access necessary medication for clients.